Works matching IS 22872728 AND DT 2025 AND VI 31 AND IP 1
Results: 78
Reply to correspondence on “Long-term gastrointestinal and hepatobiliary outcomes of COVID-19: A multinational population-based cohort study from South Korea, Japan, and the UK”.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. e123, doi. 10.3350/cmh.2024.0966
- By:
- Publication type:
- Article
Reply to correspondence on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial”.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. e121, doi. 10.3350/cmh.2024.0886
- By:
- Publication type:
- Article
Reply to correspondence on “UBE2S: A novel driver of HIF-1alpha-induced metabolic reprogramming in hepatocellular carcinoma”.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. e119, doi. 10.3350/cmh.2024.0621
- By:
- Publication type:
- Article
Reply to correspondence on “Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using vibration-controlled transient elastography: Systematic review and meta-analysis”.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. e117, doi. 10.3350/cmh.2024.0994
- By:
- Publication type:
- Article
Reply to correspondence on “Genetically-modified, redirected T cells target hepatitis B surface antigenpositive hepatocytes and hepatocellular carcinoma lesions in a clinical setting”.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. e113, doi. 10.3350/cmh.2024.0867
- By:
- Publication type:
- Article
Correspondence to letter to the editor on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial”.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. e110, doi. 10.3350/cmh.2024.0828
- By:
- Publication type:
- Article
Correspondence to letter to the editor on “Non-linear association between liver fibrosis scores and viral load in patients with chronic hepatitis B”.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. e108, doi. 10.3350/cmh.2024.0619
- By:
- Publication type:
- Article
Correspondence to letter to the editor on “Prevalence of clinically significant liver fibrosis in the general population: A systematic review and meta-analysis”.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. e105, doi. 10.3350/cmh.2024.0937
- By:
- Publication type:
- Article
Correspondence to letter to the editor on “Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis”.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. e103, doi. 10.3350/cmh.2024.0818
- By:
- Publication type:
- Article
Correspondence to letter to the editor 2 on “Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma”.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. e101, doi. 10.3350/cmh.2024.0946
- By:
- Publication type:
- Article
Correspondence to letter to the editor on “Sorafenib vs. lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: a real-world study”.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. e98, doi. 10.3350/cmh.2024.0916
- By:
- Publication type:
- Article
Correspondence to letter to the editor on “Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis”.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. e93, doi. 10.3350/cmh.2024.0943
- By:
- Publication type:
- Article
Correspondence to editorial on “UBE2S promotes glycolysis in hepatocellular carcinoma by enhancing E3 enzyme-independent polyubiquitination of VHL”.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. e58, doi. 10.3350/cmh.2024.0590
- By:
- Publication type:
- Article
Correspondence to editorial on “Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using vibration-controlled transient elastography: Systematic review and meta-analysis”.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. e55, doi. 10.3350/cmh.2024.0846
- By:
- Publication type:
- Article
Correspondence to editorial on “Optimal cutoffs of vibration-controlled transient elastography and magnetic resonance elastography in diagnosing advanced liver fibrosis in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis”.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. e52, doi. 10.3350/cmh.2024.0815
- By:
- Publication type:
- Article
Correspondence to letter to the editor 1 on “Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma”.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. e96, doi. 10.3350/cmh.2024.0999
- By:
- Publication type:
- Article
Correspondence to editorial on “Optimal cut-offs of vibration-controlled transient elastography and magnetic resonance elastography in diagnosing advanced liver fibrosis in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis”.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. e61, doi. 10.3350/cmh.2024.0878
- By:
- Publication type:
- Article
Correspondence to editorial on “Development and validation of a stromal-immune signature to predict prognosis in intrahepatic cholangiocarcinoma”.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. e90, doi. 10.3350/cmh.2024.0998
- By:
- Publication type:
- Article
Correspondence to editorial on “Long-term gastrointestinal and hepatobiliary outcomes of COVID-19: a multinational population-based cohort study from South Korea, Japan, and the UK”.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. e87, doi. 10.3350/cmh.2024.0935
- By:
- Publication type:
- Article
Correspondence to editorial 2 on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: insights from the IMbrave150 trial”.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. e84, doi. 10.3350/cmh.2024.0830
- By:
- Publication type:
- Article
Correspondence to editorial 1 on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: insights from the IMbrave150 Trial”.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. e81, doi. 10.3350/cmh.2024.0829
- By:
- Publication type:
- Article
Correspondence to editorial on “KCTD17-mediated Ras stabilization promotes hepatocellular carcinoma progression”.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. e78, doi. 10.3350/cmh.2024.0750
- By:
- Publication type:
- Article
Correspondence to editorial on “DNA methylome analysis reveals epigenetic alteration of complement genes in advanced metabolic dysfunction-associated steatotic liver disease”.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. e70, doi. 10.3350/cmh.2024.0761
- By:
- Publication type:
- Article
Correspondence to editorial on: “Gut microbiome and metabolome signatures in liver cirrhosis-related complications”.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. e74, doi. 10.3350/cmh.2024.0872
- By:
- Publication type:
- Article
Steatotic liver disease in chronic hepatitis C related hepatocellular carcinoma: Inflictor or bystander?: Correspondence to editorial on “Dynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis C patients after viral eradication: A nationwide registry study in Taiwan”.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. e64, doi. 10.3350/cmh.2024.0638
- By:
- Publication type:
- Article
PNPLA3 is one of the bridges between TM6SF2 E167K variant and MASLD: Correspondence to editorial on “TM6SF2 E167K variant decreases PNPLA3-mediated PUFA transfer to promote hepatic steatosis and injury in MASLD”.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. e67, doi. 10.3350/cmh.2024.0744
- By:
- Publication type:
- Article
Correspondence to editorial on “Prevalence of clinically significant liver fibrosis in the general population: A systematic review and meta-analysis”.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. e48, doi. 10.3350/cmh.2024.0777
- By:
- Publication type:
- Article
Correspondence to editorial on “Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting”.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. e44, doi. 10.3350/cmh.2024.0781
- By:
- Publication type:
- Article
Urgent need for education on hepatocellular carcinoma surveillance among high-risk population in China.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. e39, doi. 10.3350/cmh.2024.0813
- By:
- Publication type:
- Article
Comment: Non-invasive prediction of post-sustained virological response hepatocellular carcinoma in hepatitis C virus.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. e23, doi. 10.3350/cmh.2024.1035
- By:
- Publication type:
- Article
Letter regarding "Prevalence of clinically significant liver fibrosis in the general population”.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. e21, doi. 10.3350/cmh.2024.0887
- By:
- Publication type:
- Article
Presence of liver fibrosis in chronic hepatitis B patients with varying serum hepatitis B virus DNA levels: Letter to the editor on “Non-linear association between liver fibrosis scores and viral load in patients with chronic hepatitis B”.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. e27, doi. 10.3350/cmh.2024.0602
- By:
- Publication type:
- Article
The fibrosis-4 index for advanced liver fibrosis in NAFLD with T2DM: Half a loaf is better than no bread.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. e25, doi. 10.3350/cmh.2024.0993
- By:
- Publication type:
- Article
Chronic hepatitis B, extrahepatic malignancies and the use of antiviral drugs.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. e19, doi. 10.3350/cmh.2024.0906
- By:
- Publication type:
- Article
Sex-specific associations of metabolic dysfunctionassociated steatotic liver disease with cardiovascular outcomes.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. e35, doi. 10.3350/cmh.2024.0719
- By:
- Publication type:
- Article
Comprehensive analysis of transcriptomic biomarkers for predicting response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. e31, doi. 10.3350/cmh.2024.0628
- By:
- Publication type:
- Article
Development of risk scores for prognosis prediction among patients with early-stage hepatocellular carcinoma.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. e17, doi. 10.3350/cmh.2024.0794
- By:
- Publication type:
- Article
Letter to the editor on “Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis”.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. e15, doi. 10.3350/cmh.2024.0784
- By:
- Publication type:
- Article
Letter to the editor on “Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/ bevacizumab failure: A real-world study”.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. e13, doi. 10.3350/cmh.2024.0682
- By:
- Publication type:
- Article
Grading severity of microvascular invasion in hepatocellular carcinoma: More details, more significance.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. e10, doi. 10.3350/cmh.2024.0986
- By:
- Publication type:
- Article
Insights on risk score development: Considerations for early-stage hepatocellular carcinoma models.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. e8, doi. 10.3350/cmh.2024.0958
- By:
- Publication type:
- Article
Contemporary awareness of viral hepatitis between 2012 and 2022 among Korean adults.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. e5, doi. 10.3350/cmh.2024.0849
- By:
- Publication type:
- Article
Comparison of the therapeutic effects of transarterial radioembolization and tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. e3, doi. 10.3350/cmh.2024.0832
- By:
- Publication type:
- Article
Accountability in AI medicine: A critical appraisal of ChatGPT in patient self-management and screening.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. e1, doi. 10.3350/cmh.2024.0769
- By:
- Publication type:
- Article
Identification of KCTD17 as a Ras stabilizer in hepatocellular carcinoma: Editorial on “KCTD17- mediated Ras stabilization promotes hepatocellular carcinoma progression”.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. 304, doi. 10.3350/cmh.2024.0718
- By:
- Publication type:
- Article
Metabolic dysfunction-associated steatotic liver disease across women's reproductive lifespan and issues.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. 327, doi. 10.3350/cmh.2024.0419
- By:
- Publication type:
- Article
Understanding the impact on digestive disease in the post-COVID-19 condition: Editorial on “Long-term gastrointestinal and hepatobiliary outcomes of COVID-19: A multinational population-based cohort study from South Korea, Japan, and the UK”.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. 319, doi. 10.3350/cmh.2024.0856
- By:
- Publication type:
- Article
The urgent need for multidisciplinary approaches in managing alcohol-associated liver disease: Editorial on “The prognostic impact of psychiatric intervention on alcohol-associated liver disease: The UK Biobank cohort study”.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. 316, doi. 10.3350/cmh.2024.0847
- By:
- Publication type:
- Article
Personalized approaches to the treatment of hepatocellular carcinoma using immune checkpoint inhibitors: Editorial on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial”.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. 311, doi. 10.3350/cmh.2024.0739
- By:
- Publication type:
- Article
Transcriptomic signature in advanced hepatocellular carcinoma tissue to predict combination immunotherapy response: Editorial on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial”.
- Published in:
- Clinical & Molecular Hepatology, 2025, v. 31, n. 1, p. 308, doi. 10.3350/cmh.2024.0726
- By:
- Publication type:
- Article